EU-CLAMP

Clinical Application for Metabolic Profiling

Coordinatore	Profil Institut fur Stoffwechselforschung GmbH    more  Organization address address: Hellersbergstrasse 9 city: Neuss postcode: 41460 contact info Titolo: Dr. Nome: Tim Cognome: Heise Email: send email Telefono: 4921310000000 Fax: 4921310000000
Nazionalità Coordinatore	Germany [DE]
Totale costo	1˙186˙320 €
EC contributo	759˙837 €
Programma	FP7-SME Specific Programme "Capacities": Research for the benefit of SMEs
Code Call	FP7-SME-2010-1
Funding Scheme	BSG-SME
Anno di inizio	2010
Periodo (anno-mese-giorno)	2010-12-01   -   2012-11-30

 Partecipanti

#	participant	country	role	EC contrib. [€]
1	Profil Institut fur Stoffwechselforschung GmbH  Organization address address: Hellersbergstrasse 9 city: Neuss postcode: 41460 contact info Titolo: Dr. Nome: Tim Cognome: Heise Email: send email Telefono: 4921310000000 Fax: 4921310000000	DE (Neuss)	coordinator	249˙724.00
2	BVT Technologies, a.s.  Organization address address: Hudcova 78c city: Brno postcode: 61200 contact info Titolo: Dr. Nome: Jan Cognome: Krej?í Email: send email Telefono: +420 541 513 545 Fax: +420 541 513 266	CZ (Brno)	participant	160˙554.00
3	DATAMED SRL  Organization address address: VIA PAPA GIOVANNI XXIII 45 city: RODANO (MI) postcode: 20090 contact info Titolo: Dr. Nome: Giampiero Cognome: Porro Email: send email Telefono: 39295327090 Fax: 39295327089	IT (RODANO (MI))	participant	149˙907.00
4	Probe Scientific Ltd  Organization address address: Sir Williams Lyons Road city: Coventry postcode: CV4 7EZ contact info Titolo: Dr. Nome: Mark Cognome: O'connell Email: send email Telefono: 442476000000 Fax: 442476000000	UK (Coventry)	participant	130˙821.00
5	JOANNEUM RESEARCH FORSCHUNGSGESELLSCHAFT MBH  Organization address address: LEONHARDSTRASSE 59 city: GRAZ postcode: 8010 contact info Titolo: Mr. Nome: Joachim Cognome: Priedl Email: send email Telefono: 4369920000000 Fax: 433169000000	AT (GRAZ)	participant	24˙979.00
6	THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE  Organization address address: The Old Schools, Trinity Lane city: CAMBRIDGE postcode: CB2 1TN contact info Titolo: Ms. Nome: Renata Cognome: Schaeffer Email: send email Telefono: 441223000000 Fax: 441223000000	UK (CAMBRIDGE)	participant	23˙760.00
7	Medizinische Universitaet Graz  Organization address address: AUENBRUGGERPLATZ 2 city: GRAZ postcode: 8036 contact info Titolo: Prof. Nome: Thomas Cognome: Pieber Email: send email Telefono: 433164000000 Fax: 4331640000000	AT (GRAZ)	participant	20˙092.00

Mappa

 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

 Obiettivo del progetto (Objective)

'Europe faces a diabetes epidemic. More than 55 million people in Europe are currently diagnosed with diabetes and with an estimated 20% increase by 2030, the disease is certain to stay one of the most challenging health problems this century. Especially as diabetes no longer is a disease exclusively for adults, but affects children, young people and adults of all ages. Despite the high prevalence of diabetes, the choice of anti-diabetic drugs is still limited and two thirds of patients with diabetes do not achieve the recommended glycaemic target levels. For each new anti-diabetic drug, it is essential to investigate the metabolic effect over time. The glucose clamp technique is regarded as the gold standard to evaluate the effectiveness of new anti-diabetic drugs. There are however only a few centers with limited research capacities that have experience in using the clamp technique, because automated clamp devices are no longer commercially available and the existing techniques are confounded by a number of limitations. Increased clamp capacities are urgently needed for the development of new, more efficacious anti-diabetic drugs. Through the integration of newly emerging technologies proposed in part by the 4 participating SME organisations and with the outsourced research capacity of 3 of Europe’s leading RTD performers, the EU-CLAMP project aims to develop a new generation automated clamp device that will overcome the limitations of the existing devices by incorporating microdialysis technique for reliable continuous glucose monitoring without blood loss. The EU-CLAMP project will facilitate clamp testing in a more efficient and cost effective manner. In addition to the significant contribution that will be made to development of improved treatment options for diabetes, the project will provide a platform from which the competitiveness of the participating SMEs can be improved offering alignment to the needs of their long term business strategies.'